Almirall

Our commitment to patients is at the forefront of everything we do. This dedication is reflected in the intense 2024 performance shared by our President and CEO, Carlos Gallardo, marked by double-digit growth and continued scientific progress in Medical Dermatology. We surpassed our guidance and reinforced our leadership in the European dermatology market, driven by the continued momentum of our broad dermatology portfolio. This success is built on our commitment to advancing the scientific understanding of skin diseases and developing innovative, novel, and impactful dermatology solutions that address unmet medical needs. Our ambition is clear: to expand our impact on patients, the medical community, and society while delivering long-term value. Watch the full message from our President and CEO to learn more about our financial performance and future vision. #WeAreAlmirall #MedicalDermatology #FinancialResults

🔬#SkinAcademy made its return for the 16th edition, bringing two days of scientific exchanges and a shared commitment to advancing medical dermatology. Learn what made this edition stand out through the voices of both our experts and world-class speakers in the dermatology field. From meaningful connections to forward-thinking discussions on skin health and innovation, watch the video to discover how Skin Academy continues to elevate the future of dermatology! #MedicalDermatology #Collaboration #SkinScience

After the evaluation process led by our jury members, we are excited to announce the finalists moving forward in the #PsOlveChallenge. We initially planned to select four finalists, but the quality and impact of the proposals were so outstanding that we now have five finalists moving forward! ✨Meet the PsOlve finalists: ▪️ PsOver – Milan, Italy ▪️ PsoriBiome – Milan, Italy ▪️ Power Happy PsO – Munich, Germany ▪️ PSOSync – Sevilla, Spain ▪️ Enhancing Telemedicine for Psoriasis – Rome, Italy These projects represent innovative approaches to improving the long-term quality of life for psoriasis patients. As they enter the coaching phase, each team will work closely with experts to refine their solutions and prepare for the next stage of the challenge. A sincere thank you to all participants who shared their ideas, research, and vision. We appreciate your dedication to innovation and the future of dermatology. Stay tuned for further updates as the finalists continue their journey! #WeAreAlmirall #PsOlve #Innovation #Psoriasis

Last week we were present at the 11th World Congress of Melanoma and 21st EADO Congress in Athens with over 1200 healthcare professionals from around the globe. It was a key moment in the dermatology calendar bringing together experts, ideas and momentum for progress in the field. This year we contributed to the scientific program with our symposium named ‘’Actinic keratosis and beyond’’ which opened important conversations around patient understanding and lesion assessment. Thank you to everyone who joined and helped make these exchanges fruitful! #EADO #WeAreAlmirall #ActinicKeratosis #Melanoma #SkinCancer #Innovation 

This #WorldHealthDay, we reaffirm our commitment to those living with dermatological diseases. Our purpose is clear: to transform the world of patients by helping them realize their dreams and hopes for a healthy life. At Almirall, we understand that early support can change lives, and our dedication to making early care possible is at the core of our mission. Because caring for health today is building the well-being of tomorrow. Together, we can make a difference! #WorldHealthDay #WeAreAlmirall

The #PsOlve challenge has officially completed the enrollment phase and is now advancing to a key milestone: the coaching phase. During this stage, the finalist teams will take part in expert-led coaching sessions to refine and strengthen their proposals ahead of the final pitch. With over 20 proposals submitted from Italy, France, Germany, and Spain, this challenge has brought together universities, healthcare centers, and research institutions, all dedicated to driving innovation in psoriasis care and improving long-term patient quality of life. Before we unveil the finalists, let’s take a look at the PsOlve journey so far. 🏆 Who will move forward? The finalist teams will be announced soon—stay tuned! #WeAreAlmirall #PsOlve #Innovation #Psoriasis

We are proud that our CEO and President, Carlos Gallardo, has been recognised as one of Spain's top CEOs in the 2025 FORBES España ranking. This is a recognition of Carlos's successful leadership of Almirall and our purpose to improve people’s lives. As we are entering an era of sustained growth under Carlos´s leaderhip, we will continue advancing medical dermatology by leading science, research and development. #WeAreAlmirall #MedicalDermatology 

We’re heading to the 11th #WorldCongressOfMelanoma and 21st #EADO Congress! This event serves as a platform for the exchange of clinical experiences and research work among experts reflecting on the progress in the field of melanoma and skin cancer. The congress, bringing together professionals from around the globe, will be an invaluable opportunity for us to connect, collaborate, and contribute to the future of medical dermatology. See you there! #EADO #WeAreAlmirall #Melanoma #SkinCancer #Innovation  

Dermatological conditions can significantly impact people's lives, affecting both their physical well-being and mental health. At Almirall, we are dedicated to medical dermatology, advancing science, and innovating to deliver impactful solutions to help people realize their hopes and dreams for a healthy life.    We have participated in the programme “The Future of Dermatology: Spotlight on Skin”, where ITN Business and the British Skin Foundation explore the latest developments in dermatology.    Watch our video here: https://lnkd.in/dk-HNSn   #Dermatology #MedicalDermatology #Innovation

At the core of everything we do are innovation, science, and collaboration for the benefit of patients. We are thrilled about our partnership with RMIT University, Replior, Hospital de la Santa Creu i Sant Pau, Barcelona Health Hub, and the Digital Health Validation Center on an analytical study aimed at validating technology for detecting biomarkers related to skin diseases. This collaboration aims to enhance our knowledge in medical dermatology, involving various phases of technology validation and the association between certain biomarkers and the progression of specific skin conditions. #MedicalDermatology #DigitalInnovation #Cocreation #SkinScience #SantPau #ScienceAndTechnologyAustralia